Reprogrammed patient-derived melanoma cells induced activation and expansion of HLA-matched CD8+ T cells, giving rise to effector CCR7-CD45RA- and cytotoxic CD95+CD8+ T cells (Fig. 6J), which also resulted in higher T cell infiltration into spheroids (Fig. 6, J and K). The gene discussed is CCR7; the disease is melanoma.